Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Telemetry for cardiovascular monitoring in a pharmacological study - new approaches to data analysis

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Anderson, N. H.
  • Devlin, A. M.
  • Graham, D.
  • Morton, J. J.
  • Hamilton, C. A.
  • Reid, J. L.
  • Schork, Nicholas
  • Dominiczak, A. F.

publication date

  • January 1999

journal

  • Hypertension  Journal

abstract

  • Radio-telemetry systems offer the ability to measure blood pressure and heart rate in experimental models of hypertension without the stress artifacts induced by some other methods. We therefore aimed to develop improved, nonparametric regression methods for radio-telemetry data and to use these to assess the effects of pharmacological interventions on cardiac and vascular hypertrophy in the stroke-prone spontaneously hypertensive rat. One control group and 5 groups treated either with losartan (alone or in combination with NG-nitro-L-arginine methyl ester [ L-NAME]), perindopril (also alone or in combination with L-NAME), or hydralazine plus hydrochlorothiazide were monitored for 4 weeks. Cardiac hypertrophy was assessed by the left ventricle plus septum weight to body weight ratio and vascular hypertrophy by flow-cytometry analysis of vascular smooth muscle cell polyploidy. Hemodynamic series were split into trend and cyclic components by the seasonal and trend decomposition procedure based on Loess and compared between groups by Loess regression modeling. Systolic and diastolic blood pressures were reduced systematically by losartan and perindopril (P<10(-10)) but to a lesser extent by hydralazine plus hydrochlorothiazide (P<10(-8)), and diurnal variation was reduced in the latter group (P<10(-6)). L-NAME significantly reduced the hypotensive effect only of losartan. Vascular and cardiac hypertrophy were significantly attenuated with losartan or perindopril, but were unchanged with other treatments. The new analysis proposed here identifies differential effects on trends and cyclic variation and associations with regression of end-organ damage for losartan and perindopril compared with hydralazine plus hydrochlorothiazide. The method offers a powerful tool for detailed investigation of radio-telemetry data.

subject areas

  • Animals
  • Antihypertensive Agents
  • Aorta
  • Blood Pressure
  • Cardiomegaly
  • Cell Nucleus
  • DNA
  • Diastole
  • Female
  • Heart Rate
  • Humans
  • Hydralazine
  • Hydrochlorothiazide
  • Hypertension
  • Indoles
  • Losartan
  • Lymphocytes
  • Male
  • Muscle, Smooth, Vascular
  • NG-Nitroarginine Methyl Ester
  • Perindopril
  • Rats
  • Rats, Inbred SHR
  • Systole
  • Telemetry
  • Time Factors
scroll to property group menus

Research

keywords

  • hypertension, genetic
  • hypertrophy, cardiac
  • rats
  • statistics
  • telemetry
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0194-911X

PubMed ID

  • 9931112
scroll to property group menus

Additional Document Info

start page

  • 248

end page

  • 255

volume

  • 33

issue

  • 1

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support